Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
45k employees
Boston Scientific: Global developer and marketer of minimally invasive medical devices.
HQ
Founded
1979
Founded in 1979, Boston Scientific is a global developer, manufacturer, and marketer of minimally invasive medical devices. The company's core mission is to transform lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific offers a wide range of products used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology, and neuromodulation. The company focuses on providing advanced medical technologies to healthcare professionals and patients globally.
Notable affiliated individuals include co-founder John Abele and key investors such as Medtronic. Boston Scientific has achieved significant milestones, including pioneering advancements in stent technology and leading innovations in various therapeutic areas. The company's impact is evident in the millions of patients who have benefited from its therapies, improving their quality of life and health outcomes. Through continuous research and development, Boston Scientific remains at the forefront of medical technology, driving progress in minimally invasive treatments.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Devices
Technology
Biotech
Tags
Healthtech
Model Types
Hardware, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Consumers, Enterprise
Geographic Exposure
Global
When was Boston Scientific founded?
Boston Scientific was founded in 1979.
Where is Boston Scientific's headquarters located?
Boston Scientific's headquarters is located in Tucson, AZ, US.
When was Boston Scientific's last funding round?
Boston Scientific's most recent funding round was for $3B (USD) in March 2022.
How many employees does Boston Scientific have?
Boston Scientific has 45000 employees as of Feb 6, 2024.
How much has Boston Scientific raised to-date?
As of July 05, 2023, Boston Scientific has raised a total of $6B (USD) since Mar 4, 2022.
Add Comparison
Total Raised to Date
$6B
USD
Last Update Mar 4, 2022
Last Deal Details
$3B
USD
Mar 4, 2022
Post Ipo Debt
Current Employees
45k
Last updated: Feb 6, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts